Search

everythinglearnresearchcommunity

for

Search:↓

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

The arrector pili muscle might play a role in hair loss and needs more research to understand its impact.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Finasteride doesn't affect bone density in male rats.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

People with Down's syndrome often have more skin problems due to a weak immune system.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Undariopsis peterseniana extract helps hair grow by activating certain cell growth pathways and could be a new treatment for hair loss.

New compounds were found to help increase hair growth and decrease hair loss.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

The CORT, FGF5, and CD36 genes are crucial for the cold weather adaptation of Yanbian cattle.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.